Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
1.
J Multidiscip Healthc ; 16: 3941-3957, 2023.
Article in English | MEDLINE | ID: mdl-38089783

ABSTRACT

Background: Pregnant women are highly susceptible to periodontal disease due to changes in hormonal and immune levels, which places a huge burden on the healthcare system and requires multidisciplinary interventions. This study aimed to assess the scientific profile and research trends related to periodontal disease in pregnancy through a bibliometric approach. Methods: Publications about periodontal disease in pregnancy from 2000 to 2022 were extracted from Science Citation Index Expanded. The knowledge networks of countries, institutions, authors, journals, references, and keywords in this field were constructed using the Citespace, VOSviewer, Bibliometrix, and BIBLIOMETRIC.COM platforms. Furthermore, correlations between the characteristics of countries and the number or impact of publications were analyzed. Results: 1162 original studies and reviews were included. There was a trend toward increased publications and citations in this field. The United States had the highest academic productivity and impact by a significant margin, while correlation analyses indicated that economic power may correlate with national scientific activity. The University of North Carolina and Offenbacher S were the most influential institution and author, respectively, taking center stage in the collaborative networks. However, only several loose connections between countries or institutions were identified in the global collaborative network analysis. Six of the top ten most productive journals were in Q1 in the Journal Citation Report, and there was intensive interaction between different research subfields, such as immunology, molecular biology, and microbiology. Frontier topics were primarily clustered in two areas: (1) oral microbiology, such as microbiome, oral bacteria, and Fusobacterium nucleatum; and (2) public health, such as quality of life, pregnancy outcomes, oral health, obesity, and classification. Conclusion: Since 2000, periodontal disease in pregnancy is receiving increasingly widespread attention and is rapidly evolving at a multidisciplinary level. Oral microbiological pathogenesis and public health impact-related research deserve more exploration and may be the future direction of research. Enhanced Collaboration and interdisciplinary communication may further facilitate progress in this discipline.

2.
J Pain Res ; 16: 269-285, 2023.
Article in English | MEDLINE | ID: mdl-36744113

ABSTRACT

Purpose: Dysmenorrhea is the most common gynecological condition among women of childbearing age and remains a challenging public health issue. This study aimed to visualize profiles and hotspots in dysmenorrhea research through a bibliometric analysis to deepen the understanding of knowledge in this field. Methods: Articles and reviews on dysmenorrhea published from 2000 to 2021 were collected. We summarized standard bibliometric indicators. Publications were systematically assessed in terms of country, institution, author, journal, reference, and keywords using Citespace, VOSviewer, Bibliometric, and an online platform. Besides, correlation analyses of country-specific characteristics and bibliometric indicators were performed. Results: 3407 publications were included. Dysmenorrhea-related publications have been increasing steadily annually. China and the United States were the most productive and academically influential countries, respectively. Correlation analysis revealed that economic power is an essential factor influencing scientific activity. However, collaboration in dysmenorrhea research remained weak. Natl Yang Ming Univ and Vercellini P were the most productive institution and influential author, respectively. A significant proportion of dysmenorrhea research was published in high-impact journals and it was explored at a multidisciplinary level. Current research topics focus on two primary areas: (1) pathophysiology, such as pathogenesis, oxidative stress, and functional connectivity, and (2) public health impacts, such as quality of life, burden, depression, and exercise. Conclusion: Dysmenorrhea research has received extensive attention from scholars and is rapidly evolving. Improved collaboration and interdisciplinary exploration may advance this field. Public health research and pathophysiological exploration of dysmenorrhea are current research hotspots and may also be a focus of research in the coming years.

3.
Cell Cycle ; 17(3): 309-318, 2018.
Article in English | MEDLINE | ID: mdl-29228869

ABSTRACT

An accumulated evidence supports that MicroRNAs (miRNAs) have shown a prominent role in pathological processes and different tumor onset. However, to date, the potential functional roles and molecular mechanisms by how microRNA-424-5p(miR-424-5p) affects cancer cell proliferation are greatly unclear, especially in epithelial ovarian cancer(EOC).In this study, we demonstrated that miR-424-5p was significantly down-regulated in EOC tissues and cell lines. The level of miR-424-5p was negatively correlated with tumor size, TNM stage, pathological grade, lymphatic metastasis of EOC. Restoring miR-424-5p expression in EOC cells dramatically suppressed cell proliferation and caused an accumulation of cells in G1 phase, and thus contributed to better prognosis of EOC patients. Mechanistically, miR-424-5p inhibits CCNE1 expression through targeting CCNE1 3'UTR, and subsequent arrest cell cycle in G1/G0 phase by inhibiting E2F1-pRb pathway. This study revealed functional and mechanistic links between miR-424-5p and CCNE1 in the progression of EOC and provide an important insight into that miR-424-5p may serve as a therapeutic target in EOC.


Subject(s)
Biomarkers, Tumor/metabolism , Carcinoma, Ovarian Epithelial/genetics , Cyclin E/metabolism , MicroRNAs/metabolism , Oncogene Proteins/metabolism , 3' Untranslated Regions/genetics , Base Sequence , Carcinoma, Ovarian Epithelial/pathology , Cell Cycle/genetics , Cell Line, Tumor , Cell Proliferation/genetics , Cell Survival/genetics , Cyclin E/genetics , Female , Gene Expression Regulation, Neoplastic , Humans , MicroRNAs/genetics , Middle Aged , Models, Biological , Oncogene Proteins/genetics , Prognosis
4.
Gynecol Endocrinol ; 31(1): 40-3, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25208301

ABSTRACT

PURPOSE: To investigate the influence of the cytochrome P450 17α (CYP17A1) gene -34T/C polymorphism in the pathogenesis of polycystic ovary syndrome (PCOS) in Han Chinese population. METHODS: Three-hundred eighteen patients with PCOS and 306 controls were recruited and the CYP17A1 -34T/C polymorphism was genotyped using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Furthermore, the relationship of CYP17A1 -34T/C polymorphism and clinical feature parameters of PCOS patients was also analyzed. RESULTS: The prevalence rates of CYP17A1 genotype TT, TC and CC were 49.69%, 43.71% and 6.6% in the case group and those were 44.77%, 46.08% and 9.15% in the control group. The frequencies of CYP17A1 T and C alleles were 71.54% and 28.46% in the case group, and those were 67.81% and 32.19% in the control group. Neither the genotypic nor the allelic distribution was significantly different between the cases and controls. However, the PCOS patients with the genotype of CC had significantly higher total testosterone levels and Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) than those with the genotype of TT or TC. CONCLUSIONS: The CYP17A1 gene -34T/C polymorphism might not be directly correlated with the PCOS, but might influence PCOS via the association of testosterone level and the HOMA-IR.


Subject(s)
Genetic Predisposition to Disease , Genotype , Polycystic Ovary Syndrome/genetics , Polymorphism, Single Nucleotide , Steroid 17-alpha-Hydroxylase/genetics , Adult , Alleles , Asian People/genetics , Female , Genetic Association Studies , Humans , Insulin Resistance/genetics , Polycystic Ovary Syndrome/blood , Testosterone/blood , Young Adult
5.
Med Sci Monit ; 20: 980-7, 2014 Jun 14.
Article in English | MEDLINE | ID: mdl-24929083

ABSTRACT

BACKGROUND: The TESTIN gene was demonstrated to be a tumor suppressor in prostate and breast cancer through inhibiting tumor growth and invasion. Herein, we aimed to investigate the detailed functions of TESTIN in the highly sexual hormone (estrogen)-dependent malignancy, endometrial carcinoma. MATERIAL AND METHODS: TESTIN mRNA and protein expression were measured by qRT-PCR, Western blot and immunohistochemistry. Upregulation of TESTIN was achieved by transfecting the pcDNA3.1-TESTIN plasmids into AN3CA cells. Knockdown of TESTIN was achieved by transfecting the shRNA-TESTIN into Ishikawa cells. MTT assay, colony formation assay, and Transwell assay were used to investigate the effects of TESTIN on cellular proliferation and invasion. The apoptotic status and cell cycle were analyzed using flow cytometry. MMP2 secretion was determined by ELISA assay. The xenograft assay was used to investigate the functions of TESTIN in nude mice. RESULTS: Compared to the non-malignant adjacent endometrium, 54% of tumor samples presented downregulation of TESTIN (P<0.001). Loss of TESTIN protein was correlated with advanced tumor stage (P=0.047), high grade (P=0.034), and lymphatic vascular space invasion (P=0.036). In vitro, overexpression of TESTIN suppressed cell proliferation, induced dramatic G1 arrest, and inhibited tumor invasion through blocking the secretion of MMP2. Loss of TESTIN accelerated cellular proliferation, promoted cell cycle progression, and enhanced tumor invasion by increasing the secretion of MMP2. Consistently, TESTIN could significantly delay the growth of xenografts in nude mice. CONCLUSIONS: TESTIN was commonly downregulated in human endometrial carcinoma and was associated with poor prognostic markers. Moreover, TESTIN significantly inhibited tumor growth and invasion via arresting cell cycle in in vitro and in vivo experiments. Therefore, we propose that TESTIN might be a prognostic marker and therapeutic target for endometrial carcinoma.


Subject(s)
Cell Cycle , Cytoskeletal Proteins/metabolism , Endometrial Neoplasms/metabolism , Endometrial Neoplasms/pathology , LIM Domain Proteins/metabolism , Animals , Apoptosis , Cell Line, Tumor , Cell Proliferation , Down-Regulation , Endometrium/metabolism , Endometrium/pathology , Female , Gene Knockdown Techniques , Humans , Mice, Inbred BALB C , Mice, Nude , Middle Aged , Neoplasm Invasiveness , RNA-Binding Proteins , Xenograft Model Antitumor Assays
SELECTION OF CITATIONS
SEARCH DETAIL